Imagenebio Inc IMA

$3.75 -0.22 (-5.54%)

Valuation

Market cap
46,596,000
Revenue TTM
$800,000
Net income TTM
$-45,350,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-5,668.75%
Debt to equity
0.00

Trading

Volume
17,246
Avg volume
14,356
Day's range
$3.60 – $4.12
Shares out
11,351,000
Stochastic %K
14%
Beta
0.83
Analysts
Moderate Buy
Price target
$18.00

Price

Company profile

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Onco...

Show more

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Industry
Biotechnology
Sector
Healthcare
Phone
858 345 6265
Website
https://www.inmagenebio.com
Address
12526 High Bluff Drive, Suite 345, San Diego, United States

Latest news

Stocktwits

d_risk Nov 9, 9:40 PM
$IMA - ImageneBio, Inc. - 10-Q - Updated Risk Factors ImageneBio warns that safety findings for other OX40/OX40L therapies could affect olevaprubart development. #riskfactors #secfilings 🟢 Added 🟠 Removed https://d-risk.ai/IMA?filing=bE_oDKFl-WdUU69OUe-lo
0 replies
ClaxtonGenZ Nov 4, 5:25 AM
$IMA don't know what tomorrow will bring, but I'm looking forward to finding out
0 replies
J7263 Sep 9, 12:19 AM
$IMA continues to age well 🤣
0 replies
SybilDorsett Aug 21, 1:26 PM
$IMA COVERAGE INITIATED: ImageneBio (IMA) initiated by H.C. Wainwright. Initial rating Buy. 8:40 AM ET 8/21/2026
0 replies
J7263 Aug 12, 3:36 AM
$IMA still a stick in the mud.
0 replies
_DannyGh8st Jul 26, 2:28 PM
$IMA Insurance brokerage growth: Benefits from rising demand for commercial insurance and risk management✅
0 replies
SuperGreenToday Jun 18, 7:12 PM
$IMA
0 replies
J7263 May 29, 8:25 PM
$IMA stick in the mud. That opportunity cost 😬
0 replies